Posts
Our portfolio company, Sentilla raised $15M in a Series C funding we announced today. We were happy to support Sentilla which is the leading provider of IT infrastructure software that discovers, monitors, analyzes, plans and automates data center workloads. The funding round was led by SingTel Innov8 Ventures, the corporate venture arm of the SingTel […]
Read More
Venture capital is about nourishing the growth of highly promising young companies to help build a better economic future. So I was naturally pleased to host a group of summer interns at Claremont Creek recently because they were interested in learning more about venture and how we work. The group has been involved with the […]
Read More
VCs say they have seen the rising interest first hand. Nat Goldhaber, managing director of Claremont Creek Ventures, says seven of his portfolio companies have received interest from corporates in the past three months. At this time last year, none had. August 8, 2011 source: Venture Capital Journal Corporate VCs are more active again as […]
Read More
Our portfolio company Shotspotter, the market leader and innovator in gunshot detection and location technology and acoustic surveillance, recently announced the findings of the ShotSpotter Gunshot Location System Efficacy Study, a first-ever analyst report on the capability and effectiveness of the gunshot location system as a critical technology for public safety, police and law enforcement. […]
Read More
August 2, 2011 source: this post appeared originally at Xconomy For a first-time entrepreneur, dealing with a venture capitalist can involve an equal mix of excitement and apprehension. If the VC has any sort of reputation or prominence, entrepreneurs are often grateful simply to be pitching their idea in the first place. Should discussions get […]
Read MoreI will be moderating a panel, Venture Capitalists’ Best Practices on Commercializing Innovation at the Molecular Diagnostics World Congress on September 29, 2011 at the South San Francisco Conference Center. Here’s the panel topic summary, hope to see you there. Successful venture capital investing in molecular diagnostics requires proper commercialization of innovation. But how does this innovation get […]
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.